{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:02:36Z","timestamp":1790906556260,"version":"4.1.0"},"reference-count":167,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015982","name":"Midwest Athletes Against Childhood Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004702","name":"Baxter International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004702","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.jaci.2012.07.002","type":"journal-article","created":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T04:04:18Z","timestamp":1346126658000},"page":"S1-S24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":432,"special_numbering":"S","title":["Use and interpretation of diagnostic vaccination in primary immunodeficiency: A\u00a0working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology"],"prefix":"10.1016","volume":"130","author":[{"given":"Jordan S.","family":"Orange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ballow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Richard","family":"Stiehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhair K.","family":"Ballas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Chinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maite","family":"De La Morena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinakantha","family":"Kumararatne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry O.","family":"Harville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Hesterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majed","family":"Koleilat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"McGhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena E.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Raasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Scherzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Seroogy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarnoud","family":"Huissoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo U.","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Katial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2012.07.002_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.iac.2008.01.004","article-title":"Genetic diagnosis of primary immune deficiencies","volume":"28","author":"Morra","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2012.07.002_bib2","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jaci.2009.10.013","article-title":"Primary immunodeficiencies: 2009 update","volume":"124","author":"Notarangelo","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"issue":"suppl","key":"10.1016\/j.jaci.2012.07.002_bib4","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"94","author":"Bonilla","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib5","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/infdis\/169.4.847","article-title":"Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel","volume":"169","author":"Zangwill","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2012.07.002_bib6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2567.2004.01971.x","article-title":"Haemophilus influenzae type b conjugate vaccines","volume":"113","author":"Kelly","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2012.07.002_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-3476(05)81186-2","article-title":"Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants","volume":"121","author":"Granoff","year":"1992","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2012.07.002_bib8","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/infdis\/149.6.1034","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b","volume":"149","author":"Anderson","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2012.07.002_bib9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1517\/13543784.7.2.245","article-title":"Meningococcal vaccine development: a novel approach","volume":"7","author":"Fusco","year":"1998","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jaci.2012.07.002_bib10","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/S0264-410X(00)00050-5","article-title":"Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial","volume":"18","author":"Choo","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2012.07.002_bib11","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJM197709292971302","article-title":"Clinical efficacy of meningococcus group A\u00a0capsular polysaccharide vaccine in children three months to five years of age","volume":"297","author":"Peltola","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2012.07.002_bib12","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1128\/IAI.67.9.4862-4869.1999","article-title":"B- and T-cell immune responses to pneumococcal conjugate vaccines: divergence between carrier- and polysaccharide-specific immunogenicity","volume":"67","author":"McCool","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaci.2012.07.002_bib13","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1016\/S0264-410X(01)00238-9","article-title":"Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine","volume":"19","author":"Jones","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2012.07.002_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4161\/hv.3.5.4216","article-title":"Rabies antibody levels in bat handlers in the United Kingdom: immune response before and after purified chick embryo cell rabies booster vaccination","volume":"3","author":"Morris","year":"2007","journal-title":"Human vaccines"},{"key":"10.1016\/j.jaci.2012.07.002_bib15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(00)72515-3","article-title":"Persistence of antitoxin in man following active immunisation","volume":"242","author":"Evans","year":"1943","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2012.07.002_bib16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1056\/NEJM199503233321201","article-title":"A population-based serologic survey of immunity to tetanus in the United States","volume":"332","author":"Gergen","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2012.07.002_bib17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.clim.2007.04.011","article-title":"Active vaccination in patients with common variable immunodeficiency (CVID)","volume":"124","author":"Goldacker","year":"2007","journal-title":"Clinical Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib18","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1016\/j.vaccine.2007.05.021","article-title":"Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies","volume":"25","author":"Rezaei","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2012.07.002_bib19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/cdli.4.2.168-172.1997","article-title":"Characterization of specific immunoglobulin G (IgG) and its subclasses (IgG1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population: proposal for response criteria","volume":"4","author":"Rodrigo","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib20","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.clim.2008.02.013","article-title":"Memory B cells in common variable immunodeficiency: clinical associations and sex differences","volume":"128","author":"Sanchez-Ramon","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/15476910802129646","article-title":"The four most common pediatric immunodeficiencies","volume":"5","author":"Stiehm","year":"2008","journal-title":"J Immunotoxicol"},{"key":"10.1016\/j.jaci.2012.07.002_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10875-007-9103-1","article-title":"Population prevalence of diagnosed primary immunodeficiency diseases in the United States","volume":"27","author":"Boyle","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1081-1206(10)60665-5","article-title":"Assessment and clinical interpretation of reduced IgG values","volume":"99","author":"Agarwal","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"suppl","key":"10.1016\/j.jaci.2012.07.002_bib24","doi-asserted-by":"crossref","first-page":"S525","DOI":"10.1016\/j.jaci.2006.01.015","article-title":"Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology","volume":"117","author":"Orange","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0091-6749(93)90179-J","article-title":"Therapy for patients with recurrent infections and low serum IgG3 levels","volume":"92","author":"Barlan","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib26","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1056\/NEJM198511143132002","article-title":"Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency","volume":"313","author":"Umetsu","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2012.07.002_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/clin.1997.4386","article-title":"Selective IgG1 deficiency","volume":"84","author":"Lacombe","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jaci.2012.07.002_bib28","first-page":"507","article-title":"Serum immunoglobulins and IgG subclass levels in adults with chronic sinusitis: evidence for decreased IgG3 levels","volume":"72","author":"Armenaka","year":"1994","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaci.2012.07.002_bib29","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0140-6736(92)91769-5","article-title":"Immunodeficiency presenting as hypergammaglobulinaemia with IgG2 subclass deficiency","volume":"340","author":"Shield","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2012.07.002_bib30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-3476(98)70195-7","article-title":"The outcome of patients with hypogammaglobulinemia in infancy and early childhood","volume":"133","author":"Dalal","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2012.07.002_bib31","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S1081-1206(10)61085-X","article-title":"Impaired specific antibody response and increased B-cell population in transient hypogammaglobulinemia of infancy","volume":"97","author":"Dorsey","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/039463200802100211","article-title":"A prospective study on children with initial diagnosis of transient hypogammaglobulinemia of infancy: results from the Italian Primary Immunodeficiency Network","volume":"21","author":"Moschese","year":"2008","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jaci.2012.07.002_bib33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood.V55.2.243.243","article-title":"The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets","volume":"55","author":"Ochs","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2012.07.002_bib34","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-3476(05)82002-5","article-title":"A multiinstitutional survey of the Wiskott-Aldrich syndrome","volume":"125","author":"Sullivan","year":"1994","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2012.07.002_bib35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2223\/JPED.1460","article-title":"Response to polysaccharide antigens in patients with ataxia-telangiectasia","volume":"82","author":"Guerra-Maranhao","year":"2006","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.jaci.2012.07.002_bib36","first-page":"208","article-title":"Defective anti-polysaccharide antibody response in patients with ataxia-telangiectasia","volume":"46","author":"Sanal","year":"2004","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.jaci.2012.07.002_bib37","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2249.2005.02791.x","article-title":"Pneumococcal conjugate vaccine followed by pneumococcal polysaccharide vaccine; immunogenicity in patients with ataxia-telangiectasia","volume":"140","author":"Stray-Pedersen","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib38","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1399-3038.2006.00409.x","article-title":"Humoral immune responses and CD27+ B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome)","volume":"17","author":"Finocchi","year":"2006","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib39","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/adc.86.6.422","article-title":"Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome","volume":"86","author":"Gennery","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jaci.2012.07.002_bib40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1542\/peds.112.1.101","article-title":"A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population","volume":"112","author":"Botto","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2012.07.002_bib41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00006454-198601000-00008","article-title":"Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children","volume":"5","author":"Leinonen","year":"1986","journal-title":"Pediatr Infect Dis"},{"key":"10.1016\/j.jaci.2012.07.002_bib42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0022-3476(78)80417-X","article-title":"Transient hypogammaglobulinemia of infancy: review of the literature, clinical and immunologic features of 11 new cases, and long-term follow-up","volume":"92","author":"Tiller","year":"1978","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2012.07.002_bib43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF01543105","article-title":"Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation","volume":"15","author":"Avanzini","year":"1995","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib44","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaci.2010.05.008","article-title":"Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine","volume":"126","author":"Balloch","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib45","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jaci.2010.12.1109","article-title":"Age- and serotype-dependent antibody response to pneumococcal polysaccharides","volume":"127","author":"Bossuyt","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib46","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0140-6736(86)90409-5","article-title":"Pneumococcal vaccine prevents death from acute lower-respiratory-tract infections in Papua New Guinean children","volume":"2","author":"Riley","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2012.07.002_bib47","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1086\/302054","article-title":"Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles","volume":"63","author":"Arredondo-Vega","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaci.2012.07.002_bib48","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1182\/blood.V89.8.2849","article-title":"Adenosine deaminase deficiency in adults","volume":"89","author":"Ozsahin","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2012.07.002_bib49","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1067\/mpd.2001.115970","article-title":"A mutation in Bruton\u2019s tyrosine kinase as a cause of selective anti-polysaccharide antibody deficiency","volume":"139","author":"Wood","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2012.07.002_bib50","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1542\/peds.52.5.637","article-title":"Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b","volume":"52","author":"Smith","year":"1973","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2012.07.002_bib51","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0091-6749(96)70244-0","article-title":"Anti-pneumococcal antibody response in normal subjects: a meta-analysis","volume":"98","author":"Go","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jaci.2008.09.021","article-title":"Antibody response to pneumococcal vaccination as a function of preimmunization titer","volume":"123","author":"Hare","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib53","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1016\/j.vaccine.2010.07.039","article-title":"Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the Vaccine Adverse Events Reporting System (VAERS)","volume":"28","author":"Bakare","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2012.07.002_bib54","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1016\/j.ijid.2009.02.008","article-title":"Disseminated Bacille Calmette-Guerin in Iranian children with severe combined immunodeficiency","volume":"13","author":"Sadeghi-Shabestari","year":"2009","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jaci.2012.07.002_bib55","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00006454-200008000-00022","article-title":"Disseminated infection with varicella-zoster virus vaccine strain presenting as hepatitis in a child with adenosine deaminase deficiency","volume":"19","author":"Ghaffar","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaci.2012.07.002_bib56","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1080\/00365540110027204","article-title":"Polio vaccine virus-associated meningoencephalitis in an infant with transient hypogammaglobulinemia","volume":"33","author":"Inaba","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jaci.2012.07.002_bib57","first-page":"1","article-title":"Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence","volume":"42","year":"1993","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaci.2012.07.002_bib58","series-title":"Red Book: 2009 report of the Committee on Infectious Diseases","first-page":"524","article-title":"Pneumococcal infections","author":"AAP","year":"2009"},{"key":"10.1016\/j.jaci.2012.07.002_bib59","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1081-1206(10)60572-8","article-title":"Assessment and clinical interpretation of polysaccharide antibody responses","volume":"99","author":"Paris","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib60","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/mdr.1997.3.125","article-title":"Epidemiology of pneumococcal serotypes and conjugate vaccine formulations","volume":"3","author":"Butler","year":"1997","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jaci.2012.07.002_bib61","series-title":"Vaccines","first-page":"521","article-title":"Pneumococcal conjugate vaccine and pneumococcal common protein vaccines","author":"Black","year":"2006"},{"key":"10.1016\/j.jaci.2012.07.002_bib62","first-page":"1","article-title":"Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"46","author":"CDCP","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaci.2012.07.002_bib63","series-title":"Vaccines","first-page":"569","article-title":"Pneumococcal vaccines","author":"Jackson","year":"2006"},{"key":"10.1016\/j.jaci.2012.07.002_bib64","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1086\/344235","article-title":"Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in children","volume":"186","author":"Simell","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2012.07.002_bib65","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/jcp.2004.016253","article-title":"Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria","volume":"57","author":"Zhang","year":"2004","journal-title":"J Clin Pathol"},{"issue":"suppl","key":"10.1016\/j.jaci.2012.07.002_bib66","first-page":"S78","article-title":"Polysaccharide-based pneumococcal vaccines in the prevention of acute otitis media","volume":"19","author":"Eskola","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2012.07.002_bib67","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(80)91989-3","article-title":"Pneumococcal vaccine and otitis media","volume":"2","author":"Makela","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2012.07.002_bib68","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/01.inf.0000069763.08122.1c","article-title":"Review of randomized controlled trials on pneumococcal vaccination for prevention of otitis media","volume":"22","author":"Straetemans","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaci.2012.07.002_bib69","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1086\/649839","article-title":"Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults","volume":"201","author":"Musher","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2012.07.002_bib70","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1128\/CDLI.8.2.266-272.2001","article-title":"Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay","volume":"8","author":"Concepcion","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib71","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2249.2006.03242.x","article-title":"The clinical syndrome of specific antibody deficiency in children","volume":"146","author":"Boyle","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib72","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jaci.2006.09.036","article-title":"Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children","volume":"118","author":"Kamchaisatian","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib73","first-page":"1216","article-title":"Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine","volume":"12","author":"Rose","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib74","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00006454-199808000-00005","article-title":"Response to a heptavalent conjugate of Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine","volume":"17","author":"Sorensen","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaci.2012.07.002_bib75","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0091-6749(98)70089-2","article-title":"Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations","volume":"102","author":"Sorensen","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib76","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/CVI.00112-06","article-title":"Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies","volume":"13","author":"Burton","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib77","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CVI.13.2.165-169.2006","article-title":"Use of opsonophagocytosis for the serologic evaluation of pneumococcal vaccines","volume":"13","author":"Romero-Steiner","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"suppl","key":"10.1016\/j.jaci.2012.07.002_bib78","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1093\/clinids\/3.Supplement_1.S184","article-title":"Assessment of the antibody response to pneumococcal vaccine in high-risk populations","volume":"3","author":"Landesman","year":"1981","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jaci.2012.07.002_bib79","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1081-1206(10)60035-X","article-title":"Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections","volume":"76","author":"Hidalgo","year":"1996","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib80","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1016\/j.vaccine.2006.03.088","article-title":"Total and serotype specific pneumococcal antibody titres in children with normal and abnormal humoral immunity","volume":"24","author":"Uddin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2012.07.002_bib81","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJMoa0903029","article-title":"A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults","volume":"362","author":"French","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2012.07.002_bib82","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1365-2567.2006.02436.x","article-title":"The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM conjugate vaccine","volume":"119","author":"Clutterbuck","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2012.07.002_bib83","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/S0264-410X(03)00230-5","article-title":"Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants","volume":"21","author":"Jodar","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2012.07.002_bib84","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/S0264-410X(03)00025-2","article-title":"Correlates of immunity for pneumococcal conjugate vaccines","volume":"21","author":"Lee","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2012.07.002_bib85","first-page":"1","article-title":"Humoral immune response to pneumococcal vaccination. Prevention of infections with Streptococcus pneumoniae by immunization","volume":"60","author":"Konradsen","year":"1996","journal-title":"APMIS Suppl"},{"key":"10.1016\/j.jaci.2012.07.002_bib86","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1086\/515346","article-title":"Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination","volume":"178","author":"Granoff","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2012.07.002_bib87","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1086\/529142","article-title":"Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory","volume":"46","author":"de Roux","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2012.07.002_bib88","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(07)70210-4","article-title":"Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?","volume":"7","author":"O\u2019Brien","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaci.2012.07.002_bib89","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/S0264-410X(00)00021-9","article-title":"A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers","volume":"18","author":"Blum","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2012.07.002_bib90","first-page":"1100","article-title":"Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults","volume":"11","author":"Southern","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib91","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJM198703263161306","article-title":"An immunodeficiency characterized by impaired antibody responses to polysaccharides","volume":"316","author":"Ambrosino","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2012.07.002_bib92","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0091-6749(93)90303-W","article-title":"Defective anti-pneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections","volume":"91","author":"Sanders","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib93","first-page":"17","article-title":"The multifunctional role of antibodies in the protective response to bacterial T cell-independent antigens","volume":"319","author":"Mond","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib94","series-title":"Cellular and molecular immunology","first-page":"215","article-title":"B Cell Activation and Antibody Production","author":"Abbas","year":"2007"},{"key":"10.1016\/j.jaci.2012.07.002_bib95","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1001\/jama.1996.03530430043037","article-title":"Safety and immunogenicity of serogroups A\/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children","volume":"275","author":"Lieberman","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2012.07.002_bib96","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/S0264-410X(01)00050-0","article-title":"Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A\/C polysaccharide vaccine and vaccine-naive controls","volume":"19","author":"Borrow","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2012.07.002_bib97","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1128\/CVI.00123-06","article-title":"Priming for immunologic memory in adults by meningococcal group C conjugate vaccination","volume":"13","author":"Vu","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib98","series-title":"Vaccines","first-page":"954","article-title":"Menningococcal vaccines","author":"Granoff","year":"2004"},{"key":"10.1016\/j.jaci.2012.07.002_bib99","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1086\/315284","article-title":"Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine","volume":"181","author":"Richmond","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2012.07.002_bib100","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/infdis\/175.1.200","article-title":"Induction of immunologic memory in Gambian children by vaccination in infancy with a group A\u00a0plus group C meningococcal polysaccharide-protein conjugate vaccine","volume":"175","author":"Leach","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2012.07.002_bib101","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.280.19.1685","article-title":"Induction of immunologic memory by conjugated vs. plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial","volume":"280","author":"Macdonald","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2012.07.002_bib102","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/erv.11.50","article-title":"New frontiers in meningococcal vaccines","volume":"10","author":"Anderson","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jaci.2012.07.002_bib103","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1016\/S0264-410X(99)00139-5","article-title":"Immune response to revaccination with meningococcal A\u00a0and C polysaccharides in Gambian children following repeated immunization during early childhood","volume":"17","author":"MacLennan","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2012.07.002_bib104","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1517\/14712598.5.11.1475","article-title":"Meningococcal conjugate Vaccines","volume":"5","author":"Pichichero","year":"2005","journal-title":"Expert Opin Biol"},{"key":"10.1016\/j.jaci.2012.07.002_bib105","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1128\/IAI.70.9.4946-4954.2002","article-title":"Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection","volume":"70","author":"Burrage","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaci.2012.07.002_bib106","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/cdli.4.2.156-167.1997","article-title":"Standardization and a multi-laboratory comparison of Neisseria meningitides serogroup A\u00a0and C bactericidal assays","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib107","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/CDLI.7.5.764-768.2000","article-title":"Relationship between serum bactericidal activity and serogroup-specific immunoglobulin G concentration for adults, toddlers, and infants immunized with Neisseria meningitides serogroup C vaccines","volume":"7","author":"Sikkema","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib108","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1128\/iai.62.8.3391-3395.1994","article-title":"Safety and immunogenicity of Meningococcal A\u00a0and C polysaccharide conjugate vaccine in adults","volume":"62","author":"Anderson","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaci.2012.07.002_bib109","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00006454-200102000-00007","article-title":"Safety and immunogenicity in four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants","volume":"20","author":"Rennels","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaci.2012.07.002_bib110","first-page":"1","article-title":"Prevention and control of meningococcal disease; recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"54","author":"CDCP","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaci.2012.07.002_bib111","first-page":"462","article-title":"Report from the Advisory Committee on Immunizations practices (ACIP): decision not to recommend routine vaccination of all children aged 2\u201410 years with quadrivalent meningococcal conjugate vaccine (MCV4)","volume":"57","author":"CDCP","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaci.2012.07.002_bib112","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1001\/jama.283.21.2795","article-title":"Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: a randomized controlled trial","volume":"283","author":"MacLennan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2012.07.002_bib113","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/000992280504400603","article-title":"Meningococcal conjugate vaccine in adolescents and children","volume":"44","author":"Pichichero","year":"2005","journal-title":"Clin Pediatr"},{"key":"10.1016\/j.jaci.2012.07.002_bib114","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.inf.0000148928.10057.86","article-title":"Comparative trial of the safety and immunogenicity of quadravalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine in two- to ten-year-old children","volume":"24","author":"Pichichero","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaci.2012.07.002_bib115","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1128\/IAI.71.6.3402-3408.2003","article-title":"Disparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A\u00a0and C Neisseria meningitidis-diphtheria toxoid conjugate vaccine and by a polysaccharide vaccine. D","volume":"71","author":"Harris","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaci.2012.07.002_bib116","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.inf.0000259996.95965.ef","article-title":"Use of Meningococcal vaccines in the United States","volume":"26","author":"Bilukha","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaci.2012.07.002_bib117","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1542\/peds.2005-1314","article-title":"Prevention and control of meningococcal disease: recommendations for use of meningococcal vaccines in pediatric patients","volume":"116","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2012.07.002_bib118","series-title":"Product approval information-licensing action, package insert: meningococcal (groups A, C, Y, W-135) polysaccharide vaccine Menomune","author":"FDA","year":"2005"},{"key":"10.1016\/j.jaci.2012.07.002_bib119","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2012.07.002_bib120","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/infdis\/154.6.1033","article-title":"Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children","volume":"154","author":"Lepow","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2012.07.002_bib121","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpedi.159.10.907","article-title":"Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents","volume":"159","author":"Keyserling","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jaci.2012.07.002_bib122","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1086\/317667","article-title":"Immunologic memory 5 years after meningococcal IA\/C conjugate vaccination in infancy","volume":"183","author":"MacLennan","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2012.07.002_bib123","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1016\/j.vaccine.2006.02.021","article-title":"Immune interaction between components of acellular pertussis-diphtheria-tetanus (DTaP) vaccine and Haemophilus influenza b (Hib) conjugate vaccine in a rat model","volume":"24","author":"Mawas","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2012.07.002_bib124","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2012.07.002_bib125","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1016\/j.vaccine.2008.09.041","article-title":"Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures","volume":"26","author":"J\u00e4kel","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2012.07.002_bib126","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/IAI.70.2.702-707.2002","article-title":"Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine","volume":"70","author":"Katial","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaci.2012.07.002_bib127","first-page":"1158","article-title":"Characterization of antibodies to capsular polysaccharide antigens of Haemophilus influenzae type b and Streptococcus pneumoniae in human immune globulin intravenous preparations","volume":"11","author":"Mikolajczyk","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib128","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1182\/blood.V80.5.1163.1163","article-title":"Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency","volume":"80","author":"Ochs","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2012.07.002_bib129","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1172\/JCI106756","article-title":"Immunologic responses to bacteriophage \u03c6X174 in immunodeficiency diseases","volume":"50","author":"Ochs","year":"1971","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2012.07.002_bib130","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/clim.2000.4994","article-title":"Immunologic reconstitution following bone marrow transplantation for X-linked hyper IgM syndrome","volume":"98","author":"Duplantier","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib131","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1023\/B:JOCI.0000010429.36461.6b","article-title":"Vaccination with rabies to study the humoral cellular immune response to a T-cell dependent neoantigen in man","volume":"23","author":"Brinkman","year":"2003","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib132","first-page":"328","article-title":"Dose-response effects in immunizations with keyhole limpet haemocyanin and rabies vaccine: shift in some immunodeficiency states","volume":"70","author":"Korver","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib133","first-page":"1","article-title":"Human rabies prevention\u2014United States 2008 Recommendations of the advisory committee on immunization practices","volume":"57","author":"Manning","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaci.2012.07.002_bib134","first-page":"1","article-title":"Human rabies prevention-United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"48","author":"CDCP","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaci.2012.07.002_bib135","first-page":"125","article-title":"Human immune responses in\u00a0vivo to protein (KLH) and polysaccharide (DNP-Ficoll) neoantigens: normal subjects compared with bone marrow transplant patients on cyclosporine","volume":"64","author":"Amlot","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib136","doi-asserted-by":"crossref","DOI":"10.1128\/CDLI.8.5.880-883.2001","article-title":"Human lymphocyte proliferation responses following primary immunization with rabies vaccine as antigen","volume":"8","author":"Ghaffari","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib137","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.183.4.1623","article-title":"Rabies superantigen as a V\u03b2 T-dependent adjuvant","volume":"183","author":"Astoul","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2012.07.002_bib138","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/358507a0","article-title":"Evidence for a viral superantigen in humans","volume":"358","author":"Lafon","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2012.07.002_bib139","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1086\/313610","article-title":"Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1","volume":"30","author":"Thisyakorn","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2012.07.002_bib140","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa051568","article-title":"An antibody-deficiency syndrome due to mutations in the CD19 gene","volume":"354","author":"Van Zelm","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2012.07.002_bib141","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijid.2006.09.013","article-title":"Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans","volume":"11","author":"Muhamuda","year":"2007","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jaci.2012.07.002_bib142","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2249.2004.02439.x","article-title":"Development of an anti-Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors","volume":"136","author":"Ferry","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2012.07.002_bib143","series-title":"Code of Federal Regulations: Title 21, Volume 7, 600.3","author":"USDH","year":"2009"},{"key":"10.1016\/j.jaci.2012.07.002_bib144","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0020-7519(03)00067-5","article-title":"A review of the effectiveness of vaccine potency control testing","volume":"33","author":"McVey","year":"2003","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.jaci.2012.07.002_bib145","series-title":"The role of immunological factors in infectious, allergic, and autoimmune processes","first-page":"79","article-title":"Vaccines of pneumococcal capsular polysaccharides and the prevention of pneumococcal pneumonia","author":"Austrian","year":"1976"},{"key":"10.1016\/j.jaci.2012.07.002_bib146","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3181\/00379727-157-40010","article-title":"Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants","volume":"157","author":"Borgono","year":"1978","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.jaci.2012.07.002_bib147","series-title":"The nature and significance of the antibody response","first-page":"99","article-title":"Persistence of antibodies in man after immunization","author":"Heidelberger","year":"1953"},{"key":"10.1016\/j.jaci.2012.07.002_bib148","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00006454-199803000-00008","article-title":"Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory","volume":"17","author":"Ahman","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaci.2012.07.002_bib149","first-page":"2726","article-title":"Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid","volume":"17","author":"Ahman","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2012.07.002_bib150","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1086\/514063","article-title":"Infant immunization with pneumococcal CRM197 vaccines: effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines","volume":"176","author":"Daum","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2012.07.002_bib151","series-title":"Requirements for diphtheria, tetanus, pertussis and combined vaccines. Technical Report Series No. 800","author":"WHO","year":"1990"},{"key":"10.1016\/j.jaci.2012.07.002_bib152","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/01.inf.0000220209.35074.0b","article-title":"The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody","volume":"25","author":"Lieberman","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaci.2012.07.002_bib153","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.1977.03280250039019","article-title":"Protective efficacy of pneumococcal polysaccharide vaccines","volume":"238","author":"Smit","year":"1977","journal-title":"JAMA"},{"issue":"suppl\u00a01","key":"10.1016\/j.jaci.2012.07.002_bib154","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/0264-410X(93)90160-Y","article-title":"Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines","volume":"11","author":"Granoff","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2012.07.002_bib155","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/00006454-198707000-00008","article-title":"Factors influencing immunogenicity and safety of two Haemophilus influenzae type b polysaccharide vaccines in children 18 and 24 months of age","volume":"6","author":"Greenberg","year":"1987","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaci.2012.07.002_bib156","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0264-410X(03)00013-6","article-title":"Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants","volume":"21","author":"Zangwill","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2012.07.002_bib157","first-page":"209","article-title":"Potency status and efficacy of measles vaccine administered in Nigeria: a case study of three EPI centres in Lagos, Nigeria","volume":"28","author":"Omilabu","year":"1999","journal-title":"Afr J Med Sci"},{"key":"10.1016\/j.jaci.2012.07.002_bib158","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1086\/320713","article-title":"Diphtheria antitoxin levels among children primed with a diphtheria and tetanus toxoids and acellular pertussis vaccine lot with a subpotent diphtheria toxoid component","volume":"183","author":"Jackson","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2012.07.002_bib159","first-page":"619","article-title":"Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus","volume":"74","author":"Dietz","year":"1996","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jaci.2012.07.002_bib160","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0196-0644(97)70005-2","article-title":"Immunologic response to tetanus toxoid in geriatric patients","volume":"30","author":"Alagappan","year":"1997","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jaci.2012.07.002_bib161","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00042560-199812150-00005","article-title":"Time course of antibody response to tetanus toxoid and pneumococcal capsular polysaccharides in patients infected with HIV","volume":"19","author":"Talesnik","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"suppl","key":"10.1016\/j.jaci.2012.07.002_bib162","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1097\/00006454-199809001-00005","article-title":"Haemophilus influenzae type b conjugate vaccines: a review of efficacy data","volume":"17","author":"Heath","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaci.2012.07.002_bib163","first-page":"279","article-title":"Haemophilus influenzae vaccines: 1997","volume":"13","author":"Murphy","year":"1997","journal-title":"Adv Pediatr Infect Dis"},{"key":"10.1016\/j.jaci.2012.07.002_bib164","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.inf.0000151022.92222.be","article-title":"Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age","volume":"24","author":"K\u00e4yhty","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaci.2012.07.002_bib165","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2012.07.002_bib166","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/378744","volume":"37","author":"Kilpi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2012.07.002_bib167","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.vaccine.2006.11.032","article-title":"Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006)","volume":"25","author":"Oosterhuis-Kafeja","year":"2007","journal-title":"Vaccine"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674912011037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674912011037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:36:36Z","timestamp":1758789396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674912011037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":167,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0091674912011037"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2012.07.002","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use and interpretation of diagnostic vaccination in primary immunodeficiency: A\u00a0working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2012.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}